Liping Du, Ph.D.

Biostatistician
Biostatistics, Vanderbilt University Medical Center

Presentation(s):

• Comparison of 90Y Radioembolization Outcomes for Hepatocellular Carcinoma (HCC) in TACE-refractory (T-REF) vs Treatment Naïve (TN) Patients in the RESiN Registry (NCT: 02685631)

  Sunday, March 5, 2023
  3:45 PM – 3:54 PM

  Disclosure information not submitted.

• Progression and Survival Outcomes of Hepatocellular Carcinoma (HCC) Patients within Milan Criteria Following Y90 Radioembolization Using the Radiation-Emitting SIR-Spheres in Non-Resectable Tumor (RESiN) Registry NCT 02685631

  Sunday, March 5, 2023
  3:54 PM – 4:03 PM

  Disclosure information not submitted.

• Predictive Dosimetry and Outcomes of Hepatocellular Carcinoma Following Liver Resin Microsphere Radioembolization

  Monday, March 6, 2023
  3:00 PM – 3:09 PM

  Disclosure information not submitted.

• Comparing Survival Outcomes and Toxicities of Y90 Radioembolization of Colorectal Cancer Metastatic to the Liver Between Patients Older and Younger than 70: Analysis from the RESiN Registry (NCT02685631)

  Monday, March 6, 2023
  4:12 PM – 4:21 PM

  Disclosure information not submitted.

• Assessment of Delivery, Dosimetry and Imaging Response with FLEX versus Day of Calibration Resin 90Y microspheres for Hepatocellular Carcinoma

  Wednesday, March 8, 2023
  3:00 PM – 3:09 PM

  Disclosure information not submitted.